Article Text

PDF
Agreement of Mexican rheumatologists with the ASsessment in Ankylosing Spondylitis International Working Group and the EUropean League Against Rheumatism recommendations for the management of ankylosing spondylitis
  1. J A Simón1,
  2. R Burgos-Vargas2
  1. 1Hospital General Regional No.1 IMSS, Universidad del Mayab School of Medicine, Mérida, Yucatan, Mexico
  2. 2Hospital General de Mexico, Universidad Nacional Autónoma de Mexico, Mexico
  1. Correspondence to:
    R Burgos-Vargas
    Department of Rheumatology, Hospital General de Mexico, Dr Balmis 148, Mexico DF 06726, Mexico

Statistics from Altmetric.com

By combining a systematic review of the literature and expert consensus,1,2 the ASsessment in Ankylosing Spondylitis (ASAS) International Working Group and the EUropean League Against Rheumatism (EULAR) produced 10 recommendations for the management of ankylosing spondylitis (ASAS and EULAR-REMAS), including a general statement about patient and disease characteristics, evaluation of efficacy, non-pharmacological and pharmacological treatment, and invasive and surgical treatment. Following ASAS advice, we investigated the level of agreement with the ASAS and EULAR-REMAS among Mexican rheumatologists.

A total of 350 board-certified rheumatologists were sent the ASAS and EULAR-REMAS and a questionnaire in two sections: (1) general data and (2) the 10 ASAS and EULAR-REMAS, each presented as a heading in Spanish followed by a 10-box scale …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.